Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Bcp12063
2. Akos015896120
3. Ac-15612
4. C-2475
5. A838434
6. Cefminox Sodium Salt, Antibiotic For Culture Media Use Only
7. 5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid,7-[[2-[[(2s)-2-amino-2-carboxyethyl]thio]acetyl]amino]-7-methoxy-3-[[(1-methyl-1h-tetrazol-5-yl)t
8. Sodium(6r,7s)-7-[[2-(2-amino-3-hydroxy-3-oxopropyl)sulfanylacetyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
| Molecular Weight | 541.6 g/mol |
|---|---|
| Molecular Formula | C16H20N7NaO7S3 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 14 |
| Rotatable Bond Count | 11 |
| Exact Mass | 541.04840381 g/mol |
| Monoisotopic Mass | 541.04840381 g/mol |
| Topological Polar Surface Area | 282 Ų |
| Heavy Atom Count | 34 |
| Formal Charge | 0 |
| Complexity | 869 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
ABOUT THIS PAGE
A A838434 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of A838434, including repackagers and relabelers. The FDA regulates A838434 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. A838434 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A A838434 supplier is an individual or a company that provides A838434 active pharmaceutical ingredient (API) or A838434 finished formulations upon request. The A838434 suppliers may include A838434 API manufacturers, exporters, distributors and traders.
A838434 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of A838434 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right A838434 GMP manufacturer or A838434 GMP API supplier for your needs.
A A838434 CoA (Certificate of Analysis) is a formal document that attests to A838434's compliance with A838434 specifications and serves as a tool for batch-level quality control.
A838434 CoA mostly includes findings from lab analyses of a specific batch. For each A838434 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
A838434 may be tested according to a variety of international standards, such as European Pharmacopoeia (A838434 EP), A838434 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (A838434 USP).
LOOKING FOR A SUPPLIER?
